SENIOR DIRECTOR, GLOBAL CLINICAL MANAGEMENT, AXIOM REAL-TIME METRICS
Toronto, Ontario, Canada
Brian Dempster has over 25 years of clinical development experience, gained across a variety of therapeutic areas and geographical regions. He began his career as a CRA before being accepted to Amgen’s Leadership and Management Program. During a decade at Amgen, Brian held program leadership positions in Oncology, Endocrinology and Bone Health in Europe Canada and the US. In 2014 Brian joined Vital Therapies (VTL) where he was instrumental in the creation and execution of clinical development strategy, overseeing the entire Phase II and Phase III programs of VTLs combined device/biotherapeutic system for the treatment of liver failure. Utilizing the Fusion® e-clinical suite in partnership with Axiom. Before Joining Axiom, Brian led the clinical development group at Endologix, where oversaw the global team involved in the pre-approval and post-market clinical development of Endologix’s products, serving patients with need for abdominal aortic aneurysm sealing and repair.